Sorted By:

Relevance


Record Number of New Medicines for Heart Disease and Stroke Now in Development

PhRMA  |  Press Release

Medicines now in the research pipeline for heart disease and stroke include 36 for high blood pressure, 33 for heart failure, 16 for heart attacks, and 22 for stroke.
https://www.phrma.org/press-release/record-number-of-new-medicines-for-heart-disease-and-stroke-now-in-development

Biopharmaceutical industry policies aim to increase access to clinical trial data

PhRMA  |  Blog Post

PhRMA members have made significant progress in developing processes for clinical trial data access schemes and translating principles into practice. 
http://catalyst.phrma.org/biopharmaceutical-industry-policies-aim-to-increase-access-to-clinical-trial-data

Deputy Vice President – Policy and Research

PhRMA  |  PhRMA Career

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone. 
https://www.phrma.org

Costs and Consequences of Not Treating High Cholesterol

PhRMA  |  Blog Post

High cholesterol is treatable for many patients and, with greater treatment rates and continued innovation, we can reduce the economic and societal impact of heart disease, and help patients live longer, healthier lives.
http://catalyst.phrma.org/costs-and-consequences-of-not-treating-high-cholesterol

Realities of Drug Importation

PhRMA  |  Graphic

Learn more about the realities of drug importation: what you think happens in Canada and what actually happens in Canada.
https://www.phrma.org/graphic/realities-of-drug-importation

PhRMA letter to Puerto Rico Secretary of Economic Development and Commerce

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org/press-release/phrma-letter-to-puerto-rico-secretary-of-economic-development-and-commerce

Survey Finds Variability in MS Treatment Preferences Among Individual Patients, and Among Stakeholder Groups.

PhRMA  |  Fact Sheet

Real Endpoints, LLC (RE), a data analytics firm focusing on assessing and quantifying pharmaceutical value, has just completed an extensive literature review and survey to tease out how different stakeholder groups assess the value of current multiple sclerosis (MS) therapies.
https://www.phrma.org/fact-sheet/survey-finds-variability-in-ms-treatment-preferences-among-individual-patients-and-among-stakeholder-groups

PhRMA Announces Dr. Richard Moscicki as New Chief Medical Officer and Executive Vice President

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org

High Cholesterol: Mapping Unmet Need

PhRMA  |  Graphic

PCSK9 inhibitors will help those who cannot be treated with existing cholesterol-lowering medicines and are just one of many opportunities for those with uncontrolled cholesterol.
https://www.phrma.org/graphic/high-cholesterol-mapping-unmet-need

New Report Shows How Supply Chain Shapes Brand-Name Medicine Prices

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $65.5 billion in 2016 alone.
https://www.phrma.org

How We’re Curing The Incurable

PhRMA  |  Blog Post

That’s why the industry continues to research other new treatments, with 75 new medicines either in clinical trials or awaiting FDA review.
http://catalyst.phrma.org/how-were-curing-the-incurable

How much are hospitals marking up the price of medicines? The answer may surprise you.

PhRMA  |  Blog Post

We welcome conversations about costs, but we need to take into account the entire biopharmaceutical supply chain, including the impact hospital markups have on access and affordability of medicines.
http://catalyst.phrma.org/how-much-are-hospitals-marking-up-the-price-of-medicines-the-answer-may-surprise-you

PhRMA & BIO release joint principles on communications with health care professionals and payers

PhRMA  |  Blog Post

Many types of data and analyses can benefit patient care, including rare disease populations, patients who participate in large registries and all of us who expect that our health care professionals and insurance companies will have access to timely, high-quality information that is accurately presented.
http://catalyst.phrma.org/phrma-bio-release-joint-principles-on-communications-with-health-care-professionals-and-payers

Innovation Spotlight: A New Era in Vaccines

PhRMA  |  Video

Scientists are not only fighting infectious diseases, but also learning how to use the body’s own immune system to treat and prevent chronic disease.
https://www.phrma.org/video/innovation-spotlight-a-new-era-in-medicine

PDUFA

PhRMA  |  From PhRMA

The PDUFA VI agreement is an important step forward in ensuring patient safety, maintaining the FDA’s high standards of regulatory review and promoting timely access to safe and effective medicines for patients.  
https://www.phrma.org/advocacy/research-development/pdufa

Future Impact: Need for New Treatments for Alzheimer’s Disease

Chartpack  |  From Our Network

The development of a new treatment that delays the onset of Alzheimer’s could reduce Medicare and Medicaid spending.
http://chartpack.phrma.org/biophrma-chartpack/advances-in-treatment/future-impact-need-for-new-treatments-for-alzheimer-s-disease

Advocacy and Mental Health Care

PhRMA  |  Video

I knew there were a lot of people just like me, and I just wanted to give them hope.”
https://www.phrma.org

PhRMA CEO Statement Following Meeting With President Trump

PhRMA  |  Blog Post

To do this, we need to reform existing laws and regulations that are currently preventing private companies from negotiating better deals and paying for medicines based on the value they provide to patients and our health care system.
http://catalyst.phrma.org/phrma-ceo-statement-following-meeting-with-president-trump

Nearly 1,000 Medicines in Development to Help Patients in Their Fight Against Cancer

PhRMA  |  Press Release

A therapy that uses nanotechnology to target the delivery of medicines to prostate cancer cells, potentially overcoming some limitations of existing treatments.
https://www.phrma.org/press-release/nearly-1-000-medicines-in-development-to-help-patients-in-their-fight-against-cancer

2015 Guiding Principle: Building on Our 2014 Focus on Patients

PhRMA  |  Blog Post

  We also celebrated our partners in academia, research and community activism who helped advance the fight against HIV/AIDS at our 3rd Annual Research and Hope Awards.
http://catalyst.phrma.org/2015-guiding-principle-building-on-our-2014-focus-on-patients

New video: Patient and researcher fight JRA together

PhRMA  |  Blog Post

Parker can live long and active lives.
http://catalyst.phrma.org/new-video-patient-and-researcher-fight-jra-together

Curbing Health Care Costs

PhRMA  |  Graphic

...
https://www.phrma.org/graphic/curbing-health-care-costs

How modernizing FDA regulations can benefit patients, providers and payers

PhRMA  |  Blog Post

PhRMA looks forward to participating in the hearing, and we hope that the agency will act expeditiously to modernize its regulations in this important area.
http://catalyst.phrma.org/how-modernizing-fda-regulations-can-benefit-patients-providers-and-payers

Joint BIO/PhRMA Statement on PDUFA Reauthorization

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $51.2 billion in 2014 alone.
https://www.phrma.org/press-release/joint-bio/phrma-statement-on-pdufa-reauthorization

PhRMA Convenes Stakeholders to Discuss Value Assessments and New Ways to Pay for Medicines

PhRMA  |  Press Release

Since 2000, PhRMA member companies have invested more than half a trillion dollars in the search for new treatments and cures, including an estimated $58.8 billion in 2015 alone.
https://www.phrma.org

You have reviewed the first 200 results out of 2653. Each page contains 25 results. You're on page 8.

prev 7 8 9 10 11 12 next